Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
Income Tax Disclosure [Abstract] |
|
Schedule of Components of Income Tax Expense (Benefit) |
The components of income tax expense for 2021, 2020 and 2019 are presented in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax Expense |
|
|
|
|
|
|
|
|
|
|
(Dollars in millions) |
2021 |
|
2020 |
|
2019 |
Current income tax expense |
|
|
|
|
|
U.S. federal |
$ |
1,076
|
|
|
$ |
1,092 |
|
|
$ |
1,136 |
|
U.S. state and local |
775
|
|
|
1,076 |
|
|
901 |
|
Non-U.S. |
985
|
|
|
670 |
|
|
852 |
|
Total current expense |
2,836
|
|
|
2,838 |
|
|
2,889 |
|
Deferred income tax expense |
|
|
|
|
|
U.S. federal |
962
|
|
|
(799) |
|
|
2,001 |
|
U.S. state and local |
491
|
|
|
(233) |
|
|
223 |
|
Non-U.S. |
(2,291) |
|
|
(705) |
|
|
211 |
|
Total deferred expense |
(838) |
|
|
(1,737) |
|
|
2,435 |
|
Total income tax expense |
$ |
1,998
|
|
|
$ |
1,101 |
|
|
$ |
5,324 |
|
|
Schedule of Effective Income Tax Rate Reconciliation |
A reconciliation of the expected U.S. federal income tax expense, calculated by applying the federal statutory tax rate, to the Corporation’s actual income tax expense, and the effective tax rates for 2021, 2020 and 2019 are presented in the following table.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Income Tax Expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount |
|
Percent |
|
Amount |
|
Percent |
|
Amount |
|
Percent |
(Dollars in millions) |
2021 |
|
2020 |
|
2019 |
Expected U.S. federal income tax expense |
$ |
7,135
|
|
|
21.0
|
% |
|
$ |
3,989 |
|
|
21.0 |
% |
|
$ |
6,878 |
|
|
21.0 |
% |
Increase (decrease) in taxes resulting from: |
|
|
|
|
|
|
|
|
|
|
|
State tax expense, net of federal benefit |
1,087
|
|
|
3.2
|
|
|
728 |
|
|
3.8 |
|
|
1,283 |
|
|
3.9 |
|
Affordable housing/energy/other credits |
(3,795) |
|
|
(11.2) |
|
|
(2,869) |
|
|
(15.1) |
|
|
(2,365) |
|
|
(7.2) |
|
Tax law changes |
(2,050) |
|
|
(6.0) |
|
|
(699) |
|
|
(3.7) |
|
|
— |
|
|
— |
|
Tax-exempt income, including dividends |
(352) |
|
|
(1.0) |
|
|
(346) |
|
|
(1.8) |
|
|
(433) |
|
|
(1.3) |
|
Changes in prior-period UTBs, including interest |
(155) |
|
|
(0.5) |
|
|
(41) |
|
|
(0.2) |
|
|
(613) |
|
|
(1.9) |
|
Nondeductible expenses |
206
|
|
|
0.6
|
|
|
324 |
|
|
1.7 |
|
|
290 |
|
|
0.9 |
|
Rate differential on non-U.S. earnings |
45
|
|
|
0.1
|
|
|
218 |
|
|
1.1 |
|
|
504 |
|
|
1.5 |
|
Other |
(123) |
|
|
(0.3) |
|
|
(203) |
|
|
(1.0) |
|
|
(220) |
|
|
(0.6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total income tax expense |
$ |
1,998
|
|
|
5.9
|
% |
|
$ |
1,101 |
|
|
5.8 |
% |
|
$ |
5,324 |
|
|
16.3 |
% |
|
Reconciliation of Change in Unrecognized Tax Benefits |
The reconciliation of the beginning unrecognized tax benefits (UTB) balance to the ending balance is presented in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of the Change in Unrecognized Tax Benefits |
|
|
|
|
|
|
(Dollars in millions) |
2021 |
|
2020 |
|
2019 |
Balance, January 1 |
$ |
1,340
|
|
|
$ |
1,175 |
|
|
$ |
2,197 |
|
Increases related to positions taken during the current year |
208
|
|
|
238 |
|
|
238 |
|
Increases related to positions taken during prior years (1)
|
265
|
|
|
99 |
|
|
401 |
|
Decreases related to positions taken during prior years (1)
|
(413) |
|
|
(172) |
|
|
(1,102) |
|
Settlements |
(23) |
|
|
— |
|
|
(541) |
|
Expiration of statute of limitations |
(55) |
|
|
— |
|
|
(18) |
|
Balance, December 31 |
$ |
1,322
|
|
|
$ |
1,340 |
|
|
$ |
1,175 |
|
(1) The sum of the positions taken during prior years differs from the $(155) million, $(41) million and $(613) million in the Reconciliation of Income Tax Expense table due to temporary items, state items and jurisdictional offsets, as well as the inclusion of interest in the Reconciliation of Income Tax Expense table.
|
Summary of Income Tax Examinations |
The table below summarizes the status of examinations by major jurisdiction for the Corporation and various subsidiaries at December 31, 2021.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax Examination Status |
|
|
|
|
|
|
|
|
Years under
Examination (1)
|
|
Status at December 31 2021 |
United States |
2017-2021 |
|
Field Examination |
California |
2012-2014 |
|
Appeals |
California |
2015-2017 |
|
Field Examination |
New York |
2016-2018 |
|
Field Examination |
United Kingdom (2)
|
2019 |
|
Field Examination |
(1) All tax years subsequent to the years shown remain subject to examination.
(2) Field examination for tax year 2020 to begin in 2022.
|
Schedule of Deferred Tax Assets and Liabilities |
Significant components of the Corporation’s net deferred tax assets and liabilities at December 31, 2021 and 2020 are presented in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred Tax Assets and Liabilities |
|
|
|
|
|
December 31 |
(Dollars in millions) |
2021 |
|
2020 |
Deferred tax assets |
|
|
|
Net operating loss carryforwards |
$ |
9,360
|
|
|
$ |
7,717 |
|
Allowance for credit losses |
3,097
|
|
|
4,701 |
|
Security, loan and debt valuations |
2,746
|
|
|
2,571 |
|
Lease liability |
2,508
|
|
|
2,400 |
|
Accrued expenses |
1,626
|
|
|
1,481 |
|
Employee compensation and retirement benefits |
1,392
|
|
|
1,582 |
|
Credit carryforwards |
705
|
|
|
484 |
|
|
|
|
|
Other |
1,160
|
|
|
1,412 |
|
Gross deferred tax assets |
22,594
|
|
|
22,348 |
|
Valuation allowance |
(1,988) |
|
|
(2,346) |
|
Total deferred tax assets, net of valuation allowance |
20,606
|
|
|
20,002 |
|
|
|
|
|
Deferred tax liabilities |
|
|
|
Equipment lease financing |
3,083
|
|
|
3,101 |
|
Right-to-use asset |
2,358
|
|
|
2,296 |
|
Fixed assets |
2,082
|
|
|
1,957 |
|
ESG-related tax credit investments |
1,387
|
|
|
1,930 |
|
Available-for-sale securities
|
1,016
|
|
|
1,701 |
|
Other |
1,527
|
|
|
1,570 |
|
Gross deferred tax liabilities |
11,453
|
|
|
12,555 |
|
Net deferred tax assets |
$ |
9,153
|
|
|
$ |
7,447 |
|
|
Schedule of Operating Loss Carryforwards |
The table below summarizes the deferred tax assets and related valuation allowances recognized for the net operating loss (NOL) and tax credit carryforwards at December 31, 2021.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Operating Loss and Tax Credit Carryforward Deferred Tax Assets |
|
|
|
|
|
|
|
|
(Dollars in millions) |
Deferred Tax Asset |
|
Valuation Allowance |
|
Net Deferred Tax Asset |
|
First Year Expiring |
|
|
|
|
|
|
|
|
Net operating losses - U.K. (1)
|
$ |
7,713 |
|
|
$ |
— |
|
|
$ |
7,713
|
|
|
None |
Net operating losses - other non-U.S. |
494 |
|
|
(253) |
|
|
241
|
|
|
Various |
Net operating losses - U.S. states (2)
|
1,153 |
|
|
(610) |
|
|
543
|
|
|
Various |
|
|
|
|
|
|
|
|
Foreign tax credits |
705 |
|
|
(705) |
|
|
—
|
|
|
After 2028 |
(1)Represents U.K. broker-dealer net operating losses that may be carried forward indefinitely.
(2)The net operating losses and related valuation allowances for U.S. states before considering the benefit of federal deductions were $1.5 billion and $772 million.
|
Summary of Tax Credit Carryforwards |
The table below summarizes the deferred tax assets and related valuation allowances recognized for the net operating loss (NOL) and tax credit carryforwards at December 31, 2021.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Operating Loss and Tax Credit Carryforward Deferred Tax Assets |
|
|
|
|
|
|
|
|
(Dollars in millions) |
Deferred Tax Asset |
|
Valuation Allowance |
|
Net Deferred Tax Asset |
|
First Year Expiring |
|
|
|
|
|
|
|
|
Net operating losses - U.K. (1)
|
$ |
7,713 |
|
|
$ |
— |
|
|
$ |
7,713
|
|
|
None |
Net operating losses - other non-U.S. |
494 |
|
|
(253) |
|
|
241
|
|
|
Various |
Net operating losses - U.S. states (2)
|
1,153 |
|
|
(610) |
|
|
543
|
|
|
Various |
|
|
|
|
|
|
|
|
Foreign tax credits |
705 |
|
|
(705) |
|
|
—
|
|
|
After 2028 |
(1)Represents U.K. broker-dealer net operating losses that may be carried forward indefinitely.
(2)The net operating losses and related valuation allowances for U.S. states before considering the benefit of federal deductions were $1.5 billion and $772 million.
|